In models of AD, AIE has been shown to accelerate adult brain Aβ42 protein levels selectively in females in both the 3xTg-AD mouse model (Barnett et al., 2022) and the APP (amyloid precursor protein)/PSEN (presenilin) mouse model (Ledesma et al., 2021). Here, APP is linked to Alzheimer disease.